Product Information

DROSPIRENONE-EE 3-0.03 MG TAB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1591 per EA under NDC 68180086873. Its NADAC has been published 216 times since Sep 28, 2022.

FDA first approved this application on Dec 18, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DROSPIRENONE-EE 3-0.03 MG TAB

DROSPIRENONE AND ETHINYL ESTRADIOL
$0.1591per EA

NDC

68180086873

Classification

Generic

Dosage Form

KIT

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA201663

FDA Approved

12/18/2012

TE Code

AB

On Market Since

4/15/2022

Price Statistics

The NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has been published 216 times since Sep 28, 2022, and over the history we have for it it has declined 24.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1591 per EA
All-time high$0.2248 (Nov 16, 2022)
All-time low$0.1445 (Jul 22, 2026)
52-week high$0.1731
52-week low$0.1445
Median price$0.1731
Average price$0.1761
Largest weekly change+27.6% (Jun 19, 2024)
Weeks tracked216
Tracking sinceSep 28, 2022

Price History

1W

0.0%

1M

+5.3%

3M

+10.1%

6M

-0.9%

1Y

-2.4%

3Y

-12.6%

5Y

N/A

All

-24.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DROSPIRENONE AND ETHINYL ESTRADIOL market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DROSPIRENONE-EE 3-0.03 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DROSPIRENONE-EE 3-0.03 MG TAB, manufactured by Lupin Pharmaceuticals Inc., is $0.1591 per EA (NDC 68180086873), effective Nov 11, 2026.

How has the price of DROSPIRENONE-EE 3-0.03 MG TAB changed over time?

Over the history we have for it, the NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has declined 24.9%. It has been tracked across 216 weekly CMS publications since Sep 28, 2022.

What are the highest and lowest recorded NADAC prices for DROSPIRENONE-EE 3-0.03 MG TAB?

Since Sep 28, 2022, the NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has ranged from a low of $0.1445 (Jul 22, 2026) to a high of $0.2248 (Nov 16, 2022), with a median of $0.1731 per EA.

Are there cheaper alternatives to DROSPIRENONE-EE 3-0.03 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of DROSPIRENONE-EE 3-0.03 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DROSPIRENONE-EE 3-0.03 MG TAB?

DROSPIRENONE-EE 3-0.03 MG TAB (NDC 68180086873) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.